// App-Quantinova.ai

: Clinical impact of a non-typeable Haemophilus influenzae (NTHi) adjuvanted vaccine in adults with chronic obstructive pulmonary disease (COPD)

Researchers

Presenter

  • Daniele Riccucci

Principal Investigators

  • Tom Wilkinson

  • Stuart Schembri

  • Christopher Brightling

  • Nawar Bakerly

  • Keir Lewis

  • William Macnee

  • Lars Rombo

  • Martin Allen

  • Paul Walker

  • Daniela Casula

  • Philippe Moris

  • Sonia Schoonbroodt

  • Marco Testa

  • Ashwani Kumar Arora

Medical Centers

  • GSK, Siena, Italy

  • University of Southampton, Faculty of Medicine, Southampton General Hospital, Southampton, United Kingdom

  • Scottish Centre for Respiratory Research, Ninewells Hospital, University of Dundee, Dundee, United Kingdom,

  • Institute for Lung Health, NIHR BRU Respiratory Med, Dept of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom,

  • Salford Royal NHS Foundation Trust, Salford, United Kingdom

  • School of Medicine, University of Swansea, Swansea, United Kingdom

  • Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom

  • Clinical Research Centre, Sörmland County Council, Uppsala University, Uppsala, Sweden

  • Department of Respiratory Medicine, University Hospital of North Tees, Stockton on Tees, United Kingdom

  • Department of Gastroenterology, University of Liverpool, Liverpool, United Kingdom

  • GSK, Rixensart, Belgium

Locations

  • Italy

  • United Kingdom

  • Sweden

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • NA

Study Id's

  • NCT02075541

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved